Advancing excellence in laboratory medicine for better healthcare worldwide

eJIFCC - The electronic Journal of the International Federation of Clinical Chemistry and Laboratory Medicine

eJIFCC masthead for web blue

| Editor-in-Chief | Editorial Board | Publisher and Copyright | Aims and Scope | Indexing | Information for Authors | eJIFCC Archive |


Click here to receive the eJIFCC


eJIFCC Volume 27 no 3 - July 2016

In this issue: Cardiac Markers. The World is Changing – Are We Ready?

eJIFCC New 2015 Thumb for web.jpg
Click here to download a PDF of the full issue.
1 Foreword of the editor
Gábor L. Kovács
2 The world is changing – are we ready?
Allan S. Jaffe
3 Analytical issues with natriuretic peptides – has this been overly simplified?
Alexander G. Semenov, Alexey G. Katrukha
4 Can natriuretic peptides be used to guide therapy?
Antoni Bayes-Genis, Josep Lupón, Allan S. Jaffe
5 High sensitivity cardiac troponin assays – how to implement them successfully
Frederick K. Korley, Allan S. Jaffe
6 Soluble ST2 and galectin-3: what we know and don’t know analytically
Thomas Mueller, Benjamin Dieplinger
7 ST2 and galectin-3: ready for prime time?
Wouter C. Meijers, A. Rogier van der Velde, Rudolf A. de Boer
8 Emerging and disruptive technologies
Larry J. Kricka

 

Editor-in-Chief

Gábor L. Kovács
Institute of Laboratory Medicine
Faculty of Medicine, University of Pécs
Pécs, Hungary

Assistant Editor

Harjit Pal Bhattoa
Department of Laboratory Medicine
University of Debrecen
Debrecen, Hungary

Editorial Board

Khosrow Adeli, The Hospital for Sick Children, University of Toronto, Canada

Borut Božič, University Medical Center, Lubljana, Slovenia

Nilda E. Fink, Universidad Nacional de La Plata, La Plata, Argentina

Mike Hallworth, Shrewsbury, UK

Andrea R. Horvath, Prince of Wales Hospital and School of Medical Sciences, University of New South Wales, Sydney, Australia

Ellis Jacobs, Alere Incorporated, New York, USA

Bruce Jordan, Roche Diagnostics, Rotkreuz, Switzerland

Evelyn Koay, National University, Singapore

Gary L. Myers,  Joint Committee for Traceability in Laboratory Medicine, US

Maria D. Pasic, Laboratory Medicine and Pathobiology, University of Toronto, Canada

Maria del C. Pasquel Carrera, College of Pharmaceutical Chemical and Biochemical Pharmaceutical, Pichincha, Equador

Oliver Racz, University of Kosice, Slovakia

Rosa Sierra Amor, Laboratorio Laquims, Veracruz, Mexico

Sanja Stankovic, Institute of Medical Biochemistry, Clinical Center of Serbia, Belgrade, Serbia

Danyal Syed, Ryancenter, New York, USA

Grazyna Sypniewska, Collegium Medicum, NC University, Bydgoszcz, Poland

Jillian R. Tate,  Queensland Royal Brisbane and Women’s Hospital, Herston, Australia

Peter Vervaart, LabMed Consulting, Australia

Stacy E. Walz, Arkansas State University, USA

 

Publisher and Copyright

IFCC Communications and Publications Division (IFCC-CPD)

Copyright © 2000-2016 International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). All rights reserved.
Contents may not be reproduced without the prior permission of the Communications and Publications Division (CPD) of the IFCC.

Aims and Scope

The electronic Journal of the IFCC (eJIFCC) is a platinum open-access journal, i.e. there is no charge to read, or to submit to this journal. Our numerous high-quality articles, debates, reviews, case studies and editorials are addressed to clinical laboratorians. The journal also publishes general news articles, IFCC publicity/news, educational materials and has a letters section. Besides offering original scientific thought in our featured columns, we provide pointers to quality resources on the world wide web. We aim to assist the development of the field of clinical chemistry and laboratory medicine worldwide. Manuscripts are fully peer reviewed and immediately free to access and download from www.ifcc.org.

The eJIFCC is a member of the Committee on Publications Ethics (COPE).

Indexing

eJIFCC is archived by PubMedCentral (http://www.ncbi.nlm.nih.gov).

Information for Authors

Manuscript preparation: Microsoft Word is preferred, with the use of 12-point font, 2cm margins and double spacing. The title page should list title, authors (first name, last name and initials), each author's affiliation during the study, including e-mail adresses, corresponding author's contact information, key words. All manuscript should be provided with structured Abstracts not longer than 250 words. This information should proceed the text of each submission. Tables should be created in a common word-processing or spreadsheet format and included within the text of the manuscript, close to the first location where they are referenced. The figures must be submitted as independent images or files, with high enough resolution for publishing and printing. All tables and figures must include a short title, with any further explanatory text to be included at the bottom of either. The maximum number of references for a review article is 75, and 40 for original papers. In-text reference numbers should be included paranthetically before punctuation. The actual references shall be presented and punctuated consistently and are to be listed sequentially following the main text, with their numbers unlinked. Manuscripts should provide any required Author's Disclosures. All studies involving human subjects must indicate that they are in compliance with the ethical principles for medical research involving human subjects, in accordance with the Declaration of Helsinki.

Submission of manuscripts: Manuscripts should be submitted to the editor-in-chief, via e-mail to: ejifcc@ifcc.org.

 
Website developed by Insoft Digital